Technical Analysis for ABT - Abbott Laboratories

Grade Last Price % Change Price Change
grade B 84.42 0.19% 0.16
ABT closed down 1.69 percent on Monday, November 18, 2019, on 1.31 times normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical ABT trend table...

Date Alert Name Type % Chg
Stochastic Sell Signal Bearish 0.19%
Upper Bollinger Band Walk Strength 0.19%
Outside Day Range Expansion 0.19%
Overbought Stochastic Strength 0.19%
Upper Bollinger Band Touch Strength 0.19%
Pocket Pivot Bullish Swing Setup -1.51%
Above Upper BB Strength -1.51%
Gapped Up Strength -1.51%
Overbought Stochastic Strength -1.51%
Upper Bollinger Band Touch Strength -1.51%

Older signals for ABT ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products worldwide. Its Established Pharmaceutical Products segment offers branded generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, pain, fever, inflammation, hypothyroidism, gynecological disorders, intrahepatic cholestasis or depressive symptoms, physiological rhythm of the colon, dyslipidemia, and hypertension, as well as provides anti-infective and influenza vaccines. The company's Diagnostic Products segment provides diagnostic systems and tests, such as immunoassay and clinical chemistry systems; assays for screening and diagnosis for drugs of abuse, cancer, therapeutic drug monitoring, fertility, and physiological and infectious diseases; genomic-based tests; hematology systems and reagents; and diagnostic systems and tests for blood analysis, as well as instruments that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detects and measures infectious agents. Its Nutritional Products segment offers pediatric and adult nutritional products comprising various forms of prepared infant and follow-on formula. The company's Vascular Products segment provides coronary, endovascular, vessel closure, and structural heart devices for the treatment of vascular disease. Abbott Laboratories also offers blood glucose monitoring meters, test strips, and data management software and accessories for people with diabetes; and medical devices for the eye, including cataract surgery, LASIK surgery, contact lens care products, and dry eye products. The company primarily serves retailers, wholesalers, hospitals, health care facilities, laboratories, physicians' offices, and government agencies. The company was founded in 1888 and is headquartered in Abbott Park, Illinois.
Medicine Cancer Life Sciences Pain Diabetes Inflammation Illinois Influenza Hypertension Health Care Products Cataract Dyslipidemia Irritable Bowel Syndrome Fever Vascular Disease Cataract Surgery Generic Pharmaceuticals Cholestasis Data Management Software Hypothyroidism
Is ABT a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 88.76
52 Week Low 65.44
Average Volume 4,418,095
200-Day Moving Average 81.0044
50-Day Moving Average 82.5492
20-Day Moving Average 83.1291
10-Day Moving Average 83.9
Average True Range 1.3521
ADX 11.42
+DI 24.4705
-DI 17.6731
Chandelier Exit (Long, 3 ATRs ) 81.84370000000001
Chandelier Exit (Short, 3 ATRs ) 84.4663
Upper Bollinger Band 85.5941
Lower Bollinger Band 80.6641
Percent B (%b) 0.73
BandWidth 5.930535
MACD Line 0.6621
MACD Signal Line 0.4585
MACD Histogram 0.2036
Fundamentals Value
Market Cap 146.39 Billion
Num Shares 1.74 Billion
EPS 0.71
Price-to-Earnings (P/E) Ratio 118.68
Price-to-Sales 4.08
Price-to-Book 3.05
PEG Ratio 1.87
Dividend 1.06
Dividend Yield 1.26%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 87.08
Resistance 3 (R3) 87.31 86.61 86.61
Resistance 2 (R2) 86.61 85.89 86.49 86.45
Resistance 1 (R1) 85.43 85.44 85.08 85.20 86.30
Pivot Point 84.73 84.73 84.55 84.61 84.73
Support 1 (S1) 83.55 84.01 83.20 83.32 82.22
Support 2 (S2) 82.85 83.56 82.73 82.07
Support 3 (S3) 81.67 82.85 81.91
Support 4 (S4) 81.44